Position
Chief Financial Officer
Company
Enveda Therapeutics, Inc.
BoulderOtherBiotechnologyDescription
Enveda, a biotechnology company, has announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim, with over 20 years of biopharmaceutical corporate development and financial leadership experience, will oversee Enveda’s financial strategy and operations, contributing to the company’s growth as it continues to develop innovative therapies.
Quick answer
Enveda Appoints Jason Kim as Chief Financial Officer (January 10, 2025). Enveda Therapeutics, Inc. is based in Boulder, Colorado, United States.
- Who is the new Chief Financial Officer at Enveda Therapeutics, Inc?
- Enveda Therapeutics, Inc. named Jason Kim Chief Financial Officer, announced January 10, 2025.
- What did Enveda Therapeutics, Inc. announce on January 10, 2025?
- Enveda, a biotechnology company, has announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim, with over 20 years of biopharmaceutical corporate development and financial leadership experience, will oversee Enveda’s financial strategy and operations, contributing to the company’s growth as it continues to develop innovative therapies.
- What does Enveda Therapeutics, Inc. do?
- Enveda Biosciences is a biotechnology company building the first high-resolution chemical map of the natural world to tackle the toughest problems in drug discovery.
- Where is Enveda Therapeutics, Inc. based?
- Enveda Therapeutics, Inc. is based in Boulder, Colorado, United States.
- Which similar companies made leadership changes around the same time?
- Pulse Biosciences, Inc. (January 10, 2025), Terremoto Biosciences (January 10, 2025), NeoGenomics (January 10, 2025) and BIOTECanada (January 10, 2025) also announced leadership changes within 45 days of Enveda Therapeutics, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pulse Biosciences Appoints Paul A. LaViolette as Chief Executive Officer (January 10, 2025)
- Terremoto Biosciences Appoints James Christensen, Ph.D., as President and Head of Research & Development (January 10, 2025)
- NeoGenomics Appoints Tony Zook as Chief Executive Officer (CEO) to Succeed Chris Smith (January 10, 2025)
- BIOTECanada Names Wendy Zatylny as President and CEO (January 10, 2025)
- Dr. Alastair Leighton Appointed as Chief Operating Officer at Chemify (January 10, 2025)
- UMDF Appoints Kristen Clifford as President and Chief Executive Officer (January 10, 2025)
Who to call at Enveda Therapeutics, Inc., and when
A new leader at Enveda Therapeutics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Enveda Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enveda Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enveda Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enveda Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enveda Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.